Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy […]
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy […]
